icon
icon
icon
icon
🏷️$300 Off
🏷️$300 Off

News /

Articles /

Walgreens Boots (WBA.US) Rises Over 7.5% On $10B Private Transaction

Market IntelFriday, Mar 7, 2025 9:50 am ET
1min read

Walgreens Boots (WBA.US) shares rose on Friday, up more than 7.5% at the time of writing to $11.41. The company has agreed to be taken private by private equity firm Sycamore Partners for about $10 billion in equity value. Sycamore will pay $11.45 per share in cash for Walgreens Boots, a premium of about 8% to the stock's closing price on Thursday. In the future, Walgreens Boots will sell its primary care businesses, including Village Medical, Summit Health and CityMD, and shareholders will also receive up to $3 per share. Walgreens Boots said the total value of the deal, including debt and potential future expenses, would be up to $23.7 billion. Walgreens Boots and Sycamore expect to complete the deal in the fourth quarter of this year.

Comments

Add a public comment...
Post
User avatar and name identifying the post author
Daniel Ross
03/08

If you're looking for a guide in crypto trading. Madelyn Brookes is the one! I earned 5,300 USD from my 1,500 USD investment. I highly recommend her to everyone else who's having a terrible experience on how to invest. Contact her on Facebook for a good guidance. ( Madelyn Brookes )or her WhatsApp +1 (206) 776-4159

1
Reply
User avatar and name identifying the post author
goodpointbadpoint
03/08
@Daniel Ross 😂
0
Reply
User avatar and name identifying the post author
rvnmsn
03/07
$WBA They delayed the quarterly earnings from March to April 8, which is 2 days before the 35-day Go Shop period. With likely good earnings, they'll have just 2 days to get better offers, which isn't enough time.
0
Reply
User avatar and name identifying the post author
Gurkaz_
03/07
@rvnmsn WBA's earnings drop could impact Sycamore's offer.
0
Reply
User avatar and name identifying the post author
AdCommercial3174
03/07
@rvnmsn Not enough time, WBA gets squeezed.
0
Reply
User avatar and name identifying the post author
foureyedgrrl
03/07
Holding $WBA long, trust the healthcare play.
0
Reply
User avatar and name identifying the post author
liano
03/07
Private equity vultures circling $WBA, better sell soon.
0
Reply
User avatar and name identifying the post author
Solarprobro4
03/07
Sycamore's move could shake up $WBA fundamentals.
0
Reply
User avatar and name identifying the post author
Aertypro
03/07
Walgreens selling easy money with Village Medical.
0
Reply
User avatar and name identifying the post author
Interesting_Award_86
03/07
$11.45 per share? Gotta love a premium deal.
0
Reply
User avatar and name identifying the post author
joaopedrosp
03/07
@Interesting_Award_86 How long u think WBA's gonna hold at this premium? Or u think it's a quick flip?
0
Reply
User avatar and name identifying the post author
applesandpearss
03/07
$WBA going private? Could be a game-changer. Less public scrutiny might mean more freedom to innovate. 🤔
0
Reply
User avatar and name identifying the post author
spanishdictlover
03/07
@applesandpearss Less scrutiny = more freedom, maybe.
0
Reply
User avatar and name identifying the post author
Bossie81
03/07
$WBA no squeeze
0
Reply
User avatar and name identifying the post author
Progress_8
03/07
Selling $WBA at a premium sounds sweet, but that $23.7B price tag includes debt. Watch out for hidden landmines.
0
Reply
User avatar and name identifying the post author
CrisCathPod
03/07
Sycamore swooping in like a phoenix 🚀
0
Reply
User avatar and name identifying the post author
James___G
03/07
$WBA going private? Could shake things up. Gotta wonder if Sycamore's got a master plan or just deep pockets.
0
Reply
User avatar and name identifying the post author
CarterUdy02
03/07
Sycamore's move is like a phoenix rising. Private equity always means big plans for restructuring. Keep your eyes peeled, folks.
0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App